Ze'ev Shaked is an accomplished pharmaceuticals executive, currently serving as the President and Chief Executive Officer of Spherics, a biopharmaceutical company that specializes in developing innovative therapies for gastrointestinal disorders. Shaked's professional journey began with pursuing a Bachelor of Science in Pharmacy from the Hebrew University in Jerusalem, followed by a Master's degree in Business Administration from the Tel Aviv University.

Shaked's career spans over 30 years, during which he held several executive-level positions in a notable number of pharmaceutical companies, including Johnson & Johnson, Bristol-Myers Squibb, and Gilead Sciences. He has an extensive background in the development and commercialization of drugs, with a focus on gastroenterology and oncology therapeutic areas. Shaked is known for his strategic thinking, strong leadership skills, and his ability to drive innovation and growth.

In his current role at Spherics, Shaked is spearheading the development, regulatory approval, and commercialization of a novel drug delivery platform, which the company claims will provide a breakthrough treatment for gastrointestinal disorders. Under his leadership, Spherics has secured several rounds of financing, expanded its operations, and brought a new generation of gastroenterology therapies closer to market launch.